Compositions and methods for the treatment or prevention of disorders relating to oxidative stress

Details for Australian Patent Application No. 2006265113 (hide)

Owner The Johns Hopkins University

Inventors Zhuang, Hean; Dore, Sylvain; Thimmulappa, Rajesh Kumar; Rangasamy, Tirumalai; Biswal, Shyam; Sakata, Yoshihito; Shah, Zahoor Ahmad; Singh, Anju

Agent Pizzeys

Pub. Number AU-A-2006265113

PCT Pub. Number WO2007/005879

Priority 60/696,485 01.07.05 US; 60/800,975 17.05.06 US

Filing date 3 July 2006

Wipo publication date 11 January 2007

International Classifications

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

4 September 2008 Section 223 Application Received

  The Johns Hopkins University An application to extend the time from 01 Feb 2008 to 01 Jun 2008 in which to enter the National Phase has been filed . Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden Town Square Woden ACT 2606

23 October 2008 Section 223 Application Allowed

  The Johns Hopkins University The time in which to enter the National Phase has been extended to 01 Jun 2008. Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden Town Square Woden ACT 2606

29 January 2009 PCT application entered the National Phase

  PCT publication WO2007/005879 Priority application(s): WO2007/005879

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006265171-Magnetorheological liquid

2006265108-Human monoclonal antibodies to programmed death ligand 1 (PD-L1)